Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity

This publication has 51 references indexed in Scilit:

• Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature
  Nanomedicine: Nanotechnology, Biology and Medicine, 2011
• Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration
  Drug Delivery, 2011
• 2′‐Methoxy‐6‐methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA_Areceptors
  British Journal of Pharmacology, 2011
• Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice
  British Journal of Pharmacology, 2011
• Nanotechnology applications for improved delivery of antiretroviral drugs to the brain
  Advanced Drug Delivery Reviews, 2010
• Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
  Neurobiology of Disease, 2010
• Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery
  International Journal of Pharmaceutics, 2009
• Solid lipid nanoparticles for targeted brain drug delivery☆
  Advanced Drug Delivery Reviews, 2007
• The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
  Nature Protocols, 2007
• Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses
  European Journal of Pharmacology: Molecular Pharmacology, 1991